These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8978926

  • 1. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
    Menache D, O'Malley JP.
    Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
    [Abstract] [Full Text] [Related]

  • 2. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari E, Fang CT, Dodd RY.
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [Abstract] [Full Text] [Related]

  • 3. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep 09; 61(175):47413-23. PubMed ID: 10160337
    [Abstract] [Full Text] [Related]

  • 4. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan 09; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 5. Prions and transfusion medicine.
    Budka H.
    Vox Sang; 2000 Jan 09; 78 Suppl 2():231-8. PubMed ID: 10938959
    [Abstract] [Full Text] [Related]

  • 6. Transfusion transmission of human prion diseases.
    Zou S, Fang CT, Schonberger LB.
    Transfus Med Rev; 2008 Jan 09; 22(1):58-69. PubMed ID: 18063192
    [Abstract] [Full Text] [Related]

  • 7. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P.
    Transfusion; 2010 May 09; 50(5):1003-6. PubMed ID: 20230536
    [Abstract] [Full Text] [Related]

  • 8. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Aug 24; 72(164):48765-801. PubMed ID: 17886394
    [Abstract] [Full Text] [Related]

  • 9. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE, Llewelyn CA, Mackenzie J, Will RG.
    Vox Sang; 2006 Oct 24; 91(3):221-30. PubMed ID: 16958834
    [Abstract] [Full Text] [Related]

  • 10. Risk of prion disease transmission from ocular donor tissue transplantation.
    Hogan RN, Brown P, Heck E, Cavanagh HD.
    Cornea; 1999 Jan 24; 18(1):2-11. PubMed ID: 9894930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P.
    Haemophilia; 2007 Dec 24; 13 Suppl 5():33-40. PubMed ID: 18078395
    [Abstract] [Full Text] [Related]

  • 13. Revised precautionary measures to reduce the possible transmission of Creutzfeldt-Jakob disease (CJD) by blood and blood products; guidance document; availability--FDA. Notice.
    Fed Regist; 1997 Sep 23; 62(184):49694-5. PubMed ID: 10173801
    [Abstract] [Full Text] [Related]

  • 14. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW, Head MW.
    Haemophilia; 2004 Oct 23; 10 Suppl 4():64-9. PubMed ID: 15479374
    [Abstract] [Full Text] [Related]

  • 15. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
    Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M.
    Neuropathology; 2009 Oct 23; 29(5):625-31. PubMed ID: 19659942
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of prion disease transmission].
    Kishida H, Kuroiwa Y.
    Nihon Rinsho; 2007 Aug 23; 65(8):1454-9. PubMed ID: 17695283
    [Abstract] [Full Text] [Related]

  • 17. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM, Dickinson J, Walker JT, Raven ND.
    Clin Infect Dis; 2006 Sep 15; 43(6):757-64. PubMed ID: 16912952
    [Abstract] [Full Text] [Related]

  • 18. Occupational risk factors for the sporadic form of Creutzfeldt-Jakob disease.
    Cocco PL, Caperna A, Vinci F.
    Med Lav; 2003 Sep 15; 94(4):353-63. PubMed ID: 14526494
    [Abstract] [Full Text] [Related]

  • 19. Creutzfeldt-Jakob disease and blood transfusion.
    Fernandez Lopez MJ, Van Everbroeck B, Pals P, Martin JJ, Cras P.
    Acta Neurol Belg; 1998 Sep 15; 98(3):247-51. PubMed ID: 9801705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.